Loci identified by a genome‐wide association study of carotid artery stenosis in the eMERGE network
暂无分享,去创建一个
Marc S. Williams | H. Hakonarson | E. Speliotes | S. Pendergrass | S. Sohn | I. Kullo | Rongling Li | C. Weng | E. Larson | G. Jarvik | D. Carrell | S. Handelman | D. Fasel | Q. Feng | A. Gordon | Daniel S. Kim | D. Crosslin | I. Stanaway | E. Rosenthal | M. Palmer | P. Sleiman | David J. Cronkite | Elizabeth K. Speliotes | Xiaomeng Du | Yatong K. Li | D. S. Kim | X. Du | Rongling Li
[1] W. Guan,et al. Race-Based Differences in Lipoprotein(a)-Associated Risk of Carotid Atherosclerosis: The Multi-Ethnic Study of Atherosclerosis , 2019, Arteriosclerosis, thrombosis, and vascular biology.
[2] Matthew S. Lebo,et al. The eMERGE genotype set of 83,717 subjects imputed to ~40 million variants genome wide and association with the herpes zoster medical record phenotype , 2018, Genetic epidemiology.
[3] George Hripcsak,et al. LPA Variants Are Associated With Residual Cardiovascular Risk in Patients Receiving Statins , 2018, Circulation.
[4] D. Tárnoki,et al. Carotid Artery Atherosclerosis: A Review on Heritability and Genetics , 2018, Twin Research and Human Genetics.
[5] James R. Staley,et al. Association of LPA Variants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies: A Mendelian Randomization Analysis , 2018, JAMA cardiology.
[6] B. Nordestgaard,et al. Advances in lipid-lowering therapy through gene-silencing technologies , 2018, Nature Reviews Cardiology.
[7] Lars G Fritsche,et al. Efficiently controlling for case-control imbalance and sample relatedness in large-scale genetic association studies , 2017, Nature Genetics.
[8] Sherri Rose,et al. Challenges in adapting existing clinical natural language processing systems to multiple, diverse health care settings , 2017, J. Am. Medical Informatics Assoc..
[9] J. Danesh,et al. Association analyses based on false discovery rate implicate new loci for coronary artery disease , 2017, Nature Genetics.
[10] M. Hoshino,et al. Neuronal Migration and AUTS2 Syndrome , 2017, Brain sciences.
[11] A. Khera,et al. Genetics of coronary artery disease: discovery, biology and clinical translation , 2017, Nature Reviews Genetics.
[12] Gonçalo R. Abecasis,et al. Phenotypic Characterization of Genetically Lowered Human Lipoprotein(a) Levels. , 2016, Journal of the American College of Cardiology.
[13] Alan M. Kwong,et al. Next-generation genotype imputation service and methods , 2016, Nature Genetics.
[14] Shane A. McCarthy,et al. Reference-based phasing using the Haplotype Reference Consortium panel , 2016, Nature Genetics.
[15] J. Schuurs-Hoeijmakers,et al. A detailed clinical analysis of 13 patients with AUTS2 syndrome further delineates the phenotypic spectrum and underscores the behavioural phenotype , 2016, Journal of Medical Genetics.
[16] Identifi cation of additional risk loci for stroke and small vessel disease : a meta-analysis of genome-wide association , 2016 .
[17] J. Danesh,et al. A comprehensive 1000 Genomes-based genome-wide association meta-analysis of coronary artery disease , 2016 .
[18] P. Elliott,et al. UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age , 2015, PLoS medicine.
[19] T. Warnow,et al. Phylogenomic analyses data of the avian phylogenomics project , 2015, GigaScience.
[20] Carson C Chow,et al. Second-generation PLINK: rising to the challenge of larger and richer datasets , 2014, GigaScience.
[21] J. Haines,et al. eMERGEing progress in genomics—the first seven years , 2014, Front. Genet..
[22] Pankaj Sharma,et al. Shared Genetic Susceptibility to Ischemic Stroke and Coronary Artery Disease: A Genome-Wide Analysis of Common Variants , 2014, Stroke.
[23] A. Khera,et al. Lipoprotein(a) Concentrations, Rosuvastatin Therapy, and Residual Vascular Risk: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention An Intervention Trial Evaluating Rosuvastatin) , 2013, Circulation.
[24] Jean-François Zagury,et al. Haplotype estimation using sequencing reads. , 2013, American journal of human genetics.
[25] O. Melander,et al. Are 25 SNPs from the CARDIoGRAM study associated with ischaemic stroke? , 2013, European journal of neurology.
[26] Melissa A. Basford,et al. The Electronic Medical Records and Genomics (eMERGE) Network: past, present, and future , 2013, Genetics in Medicine.
[27] Rex L. Chisholm. At the Interface between Medical Informatics and Personalized Medicine: The eMERGE Network Experience , 2013, Healthcare informatics research.
[28] O. Delaneau,et al. Supplementary Information for ‘ Improved whole chromosome phasing for disease and population genetic studies ’ , 2012 .
[29] Data production leads,et al. An integrated encyclopedia of DNA elements in the human genome , 2012 .
[30] ENCODEConsortium,et al. An Integrated Encyclopedia of DNA Elements in the Human Genome , 2012, Nature.
[31] P. Ridker,et al. Genetic Determinants of Statin-Induced Low-Density Lipoprotein Cholesterol Reduction: The Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) Trial , 2012, Circulation. Cardiovascular genetics.
[32] Suzette J. Bielinski,et al. Use of diverse electronic medical record systems to identify genetic risk for type 2 diabetes within a genome-wide association study , 2012, J. Am. Medical Informatics Assoc..
[33] Manolis Kellis,et al. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants , 2011, Nucleic Acids Res..
[34] W. Rathmann,et al. Meta-analysis of genome-wide association studies from the CHARGE consortium identifies common variants associated with carotid intima media thickness and plaque , 2011, Nature Genetics.
[35] M. Rieder,et al. Variation in LPA Is Associated with Lp(a) Levels in Three Populations from the Third National Health and Nutrition Examination Survey , 2011, PloS one.
[36] Gail P Jarvik,et al. Genetic Variation in LPAL2, LPA, and PLG Predicts Plasma Lipoprotein(a) Level and Carotid Artery Disease Risk , 2011, Stroke.
[37] Wendy A. Wolf,et al. The eMERGE Network: A consortium of biorepositories linked to electronic medical records data for conducting genomic studies , 2011, BMC Medical Genomics.
[38] Jin Fan,et al. Leveraging informatics for genetic studies: use of the electronic medical record to enable a genome-wide association study of peripheral arterial disease , 2010, J. Am. Medical Informatics Assoc..
[39] Alkes L. Price,et al. New approaches to population stratification in genome-wide association studies , 2010, Nature Reviews Genetics.
[40] Marylyn D. Ritchie,et al. PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene–disease associations , 2010, Bioinform..
[41] R. Collins,et al. Genetic variants associated with Lp(a) lipoprotein level and coronary disease. , 2009, The New England journal of medicine.
[42] D. Reich,et al. Principal components analysis corrects for stratification in genome-wide association studies , 2006, Nature Genetics.
[43] B. Trask,et al. Identification of a novel gene on chromosome 7q11.2 interrupted by a translocation breakpoint in a pair of autistic twins. , 2002, Genomics.
[44] D. Strandness,et al. Carotid artery duplex scanning , 1987, Journal of clinical ultrasound : JCU.